Estimating the effects of global patent protection in pharmaceuticals: A case study of quinolones in India

American Economic Review

Volumn 96, Issue 5, 2006, Pages 1477-1514

  Chaudhuri, Shubham ^a   Goldberg, Pinelopi K ^b,c   Jia, Panle ^d  

^a WORLD BANK   (United States)

^b YALE UNIVERSITY   (United States)

^c NATIONAL BUREAU OF ECONOMIC RESEARCH   (United States)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

QUINOLONE DERIVATIVE;

COMMERCIAL PHENOMENA; DEVELOPING COUNTRY; DRUG LEGISLATION; ECONOMICS; HUMAN; INDIA; LEGISLATION AND JURISPRUDENCE; PATENT; SUPPLY AND DISTRIBUTION;

COMMERCE; DEVELOPING COUNTRIES; HUMANS; INDIA; LEGISLATION, DRUG; PATENTS AS TOPIC; QUINOLONES;

EID: 33847661614     PISSN: 00028282     EISSN: None     Source Type: Journal    
DOI: 10.1257/aer.96.5.1477     Document Type: Article

References (48)

1. Andrews, Donald W. K., and Moshe Buchinsky. 2000. "A Three-Step Method for Choosing the Number of Bootstrap Repetitions." Econometrica, 68(1): 23-51.
2. Bale, Harvey E., Jr. 2001. "Consumption and Trade in Off-Patented Medicines." World Health Organization, Commission for Macroeconomics and Health Working Paper Series WG 4: 3.
3. Barton, John. 2001. "Differentiated Pricing of Patented Products." World Health Organization, Commission for Macroeconomics and Health Working Paper Series WG4: 2.
4. Berndt, Ernst R. 1994. Uniform Pharmaceutical Pricing: An Economic Analysis. Washington, DC: AEI Press.
5. Berry, Steven, James Levinsohn, and Ariel Pakes. 1995. "Automobile Prices in Market Equilibrium." Econometrica, 63(4): 841-90.
6. Bresnahan, Timothy F. 1997. "Valuation of New Goods under Perfect and Imperfect Competition: Comment." In The Economics of New Goods, ed. Timothy F. Bresnahan and Robert J. Gordon, 237-47. Chicago: University of Chicago Press.
7. Caves, Richard E., Michael D. Whinston, and Mark A. Hurwitz. 1991. "Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry." Brookings Papers on Economic Activity, Special Issue: 1-48.
8. Challu, Pablo M. 1991. "The Consequences of Pharmaceutical Product Patenting." World Competition, 15(2): 65-126.
9. Chin, Judith C., and Gene M. Grossman. 1990. "Intellectual Property Rights and North-South Trade." In The Political Economy of International Trade: Essays in Honor of Robert E. Baldwin, ed. Ronald W. Jones and Anne O. Krueger, 90-107. Cambridge, MA: Basil Blackwell.
10. Christensen, Laurits R., Dale W. Jorgenson, and Lawrence J. Lau. 1975. "Transcendental Logarithmic Utility Functions." American Economic Review, 65(3): 367-83.
11. Deardorff, Alan V. 1992. "Welfare Effects of Global Patent Protection." Economica, 59(233): 35-51.
12. Deaton, Angus S., and John Muellbauer. 1980a, "An Almost Ideal Demand System." American Economic Review, 70(3): 312-26.
13. Deaton, Angus S., and John Muellbauer. 1980b. Economics and Consumer Behavior. Cambridge: Cambridge University Press.
14. Diwan, Ishac, and Dani Rodrik. 1991. "Patents, Appropriate Technology, and North-South Trade." Journal of International Economics, 30(1-2): 27-47.
15. Efron, Bradley, and Robert J. Tibshirani. 1993. An Introduction to the Bootstrap: Monographs on Statistics and Applied Probability. Vol. 57. New York: Chapman and Hall.
16. Ellison, Sara F., lain M. Cockburn, Zvi Griliches, and Jerry A. Hausman. 1997. "Characteristics of Demand for Pharmaceutical Products: An Examination of Four Cephalosporins." RAND Journal of Economics, 28(3): 426-46.
17. Fink, Carsten. 2000. "How Stronger Patent Protection in India Might Affect the Behavior of Transnational Pharmaceutical Industries." The World Bank, Policy Research Working Paper 2352.
18. Frank, Richard G., and David S. Salkever. 1997. "Generic Entry and the Pricing of Pharmaceuticals." Journal of Economics and Management Strategy, 6(1): 75-90.
19. Ganslandt, Mattias, Keith E. Maskus, and Eina V. Wong. 2001. "Developing and Distributing Essential Medicines to Poor Countries: The DEFEND Proposal." World Economy, 24(6): 779-95.
20. Goldberg, Pinelopi K. 1995. "Product Differentiation and Oligopoly in International Markets: The Case of the U.S. Automobile Industry." Econometrica, 63(4): 891-951.
21. Grossman, Gene M., and Edwin L.-C. Lai. 2004. "International Protection of Intellectual Property." American Economic Review, 94(5): 1635-53.
22. Hausman, Jerry A. 1994. "Valuation of New Goods under Perfect and Imperfect Competition." National Bureau of Economic Research Working Paper 4970.
23. Hausman, Jerry A., and Gregory K. Leonard. 2002. "The Competitive Effects of a New Product Introduction: A Case Study." Journal of Industrial Economics, 50(3): 237-63.
24. Helpman, Elhanan. 1993. "Innovation, Imitation, and Intellectual Property Rights." Econometrica, 61(6): 1247-80.
25. Indian Credit Rating Agency. 1999. Indian Pharmaceutical Industry. New Delhi: ICRA, Industry Watch Series.
26. Kremer, Michael. 1998. "Patent Buyouts: A Mechanism for Encouraging Innovation." Quarterly Journal of Economics, 113(4): 1137-67.
27. Lanjouw, Jean O. 1998. "The Introduction of Pharmaceutical Product Patents in India: 'Heartless Exploitation of the Poor and Suffering'?" National Bureau of Economic Research Working Paper 6366.
28. Lanjouw, Jean O., and lain M. Cockburn. 2001. "New Pills for Poor People? Empirical Evidence after GATT." World Development, 29(2): 265-89.
29. Lu, Z. John, and William S. Comanor. 1998. "Strategic Pricing of New Pharmaceuticals." Review of Economics and Statistics, 80(1): 108-18.
30. th ed. Philadelphia and London: Churchill Livingstone/Harcourt Brace.
31. Maskus, Keith E. 2000. Intellectual Property Rights in the Global Economy. Washington, D.C.: Institute for International Economics.
32. Maskus, Keith E., and Denise E. Konan. 1994. "Trade-Related Intellectual Property Rights: Issues and Exploratory Results." In Analytical and Negotiating Issues in the Global Trading System, ed. Alan V. Deardorff and Robert M. Stern, 401-46. Ann Arbor, MI: University of Michigan Press.
33. Mazzoleni, Roberto, and Richard R. Nelson. 1998a. "The Benefits and Costs of Strong Patent Protection: A Contribution to the Current Debate." Research Policy, 27(3): 273-84.
34. Mazzoleni, Roberto, and Richard R. Nelson. 1998b. "Economic Theories about the Benefits and Costs of Patents." Journal of Economic Issues, 32(4): 1031-52.
35. Nevo, Aviv. 2001. "Measuring Market Power in the Ready-to-Eat Cereal Industry." Econometrica, 69(2): 307-42.
36. Nogues, Julio J. 1993. "Social Costs and Benefits of Introducing Patent Protection for Pharmaceutical Drugs in Developing Countries." Developing Economies, 31(1): 24-53.
37. Nordhaus, William D. 1969. Invention, Growth and Welfare: A Theoretical Treatment of Technological Change. Cambridge, MA: MIT Press.
38. Pollack, Andrew. April 20, 2001. "News Analysis: Defensive Drug Industry Fuels Fight over Patents," New York Times.
39. Quah, Danny. 2002. "Almost Efficient Innovation by Pricing Ideas." London School of Economics, Center for Economic Performance Working Paper 1219.
40. Rozek, Richard P., and Ruth Berkowitz. 1998. "The Effects of Patent Protection on the Prices of Pharmaceutical Products: Is Intel lectual Property Protection Raising the Drug Bill in Developing Countries." Journal of Intellectual Property, 1(2): 179-243.
41. Sachs, Jeffrey D. 2002. "A New Global Effort to Control Malaria." Science, 298(5591): 122-24.
42. Scherer, Frederic M., and Jayashree Watal. 2002. "Post-TRIPS Options for Access to Patented Medicines in Developing Nations." Journal of International Economic Law, 5(4): 913-39.
43. Stevenson, Richard W. November 15, 2001. "Measuring Success: At Least the Talks Didn't Collapse," New York Times.
44. Subramanian, Arvind. 1995. "Putting Some Numbers on the TRIPS Pharmaceutical Debate." International Journal of Technology Management, 10(2-3): 252-68.
45. Trajtenberg, Manuel. 1989. "The Welfare Analysis of Product Innovations, with an Application to Computed Tomography Scanners." Journal of Political Economy, 97(2): 444-79.
46. Wattal, Jayashree. 1996. "Introducing Product Patents in the Indian Pharmaceutical Sector - Implications for Prices and Welfare." World Competition, 20(2): 5-21.
47. Wattal, Jayashree. 2000. "Pharmaceutical Patents, Prices and Welfare Losses: Policy Options for India under the WTO TRIPS Agreement." World Economy, 23(5): 733-52.
48. Wright, Brian D. 1983. "The Economics of Invention Incentives: Patents, Prizes, and Research Contracts." American Economic Review, 73(4): 691-707.